Grant Verstandig, Director at NexImmune, Inc. (NEXI), bought 93,752 shares at $2.14 ($209K) on 2022-06-06, disclosed to the SEC on 2022-06-07.
Open-market purchase of $209k NEXI by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.22 | 15,000 | $33K | 15.9% |
| 2 | $2.14 | 25,000 | $54K | 25.6% |
| 3 | $2.28 | 26,876 | $61K | 29.3% |
| 4 | $2.28 | 26,876 | $61K | 29.3% |
| Total | $2.23 avg | 93,752 | $209K | 100% |
| Filing → |
| NEXI | BUY | 2021-02-19 | $3.0M | — | Filing → |